(IMO) Imperial Oil - Overview
Exchange: NYSE MKT •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA4530384086
Stock: Oil, Gas, Refined Products, Chemicals
Total Rating 62
Risk 80
Buy Signal 0.22
| Risk 5d forecast | |
|---|---|
| Volatility | 25.3% |
| Relative Tail Risk | 2.66% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.08 |
| Alpha | 74.08 |
| Character TTM | |
|---|---|
| Beta | 0.828 |
| Beta Downside | 1.642 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.95% |
| CAGR/Max DD | 1.61 |
EPS (Earnings per Share)
Revenue
Description: IMO Imperial Oil March 05, 2026
Imperial Oil Limited is a Canadian integrated oil and gas company. It operates across three segments: Upstream, Downstream, and Chemical.
The Upstream segment focuses on exploration and production of crude oil, natural gas, synthetic crude oil, and bitumen. This segment is fundamental to the oil and gas sector, providing raw materials for energy production.
The Downstream segment handles transportation, refining, and marketing of crude oil and refined products. This includes operating refineries and a distribution network for products sold under brands like Esso and Mobil. The refining business model transforms crude oil into various petroleum products, adding significant value.
The Chemical segment manufactures and markets aliphatic solvents, plasticizer intermediates, polyethylene resins, and refinery grade propylene. This segment diversifies the companys revenue streams beyond traditional fuels.
Imperial Oil Limited, incorporated in 1880 and headquartered in Calgary, Canada, is a subsidiary of Exxon Mobil Corporation. For deeper insights into its financial performance, consider exploring its profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 3.27b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 1.53 > 1.0 |
| NWC/Revenue: 3.83% < 20% (prev 4.81%; Δ -0.98% < -1%) |
| CFO/TA 0.16 > 3% & CFO 6.71b > Net Income 3.27b |
| Net Debt (3.84b) to EBITDA (6.83b): 0.56 < 3 |
| Current Ratio: 1.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (504.0m) vs 12m ago -2.42% < -2% |
| Gross Margin: 21.23% > 18% (prev 0.14%; Δ 2109 % > 0.5%) |
| Asset Turnover: 110.4% > 50% (prev 113.7%; Δ -3.35% > 0%) |
| Interest Coverage Ratio: 2126 > 6 (EBITDA TTM 6.83b / Interest Expense TTM 2.00m) |
Altman Z'' 3.76
| A: 0.04 (Total Current Assets 8.42b - Total Current Liabilities 6.62b) / Total Assets 42.31b |
| B: 0.51 (Retained Earnings 21.37b / Total Assets 42.31b) |
| C: 0.10 (EBIT TTM 4.25b / Avg Total Assets 42.62b) |
| D: 1.11 (Book Value of Equity 22.25b / Total Liabilities 20.05b) |
| Altman-Z'' Score: 3.76 = AA |
Beneish M -3.54
| DSRI: 0.79 (Receivables 4.37b/5.76b, Revenue 47.04b/48.82b) |
| GMI: 0.68 (GM 21.23% / 14.46%) |
| AQI: 1.11 (AQ_t 0.07 / AQ_t-1 0.06) |
| SGI: 0.96 (Revenue 47.04b / 48.82b) |
| TATA: -0.08 (NI 3.27b - CFO 6.71b) / TA 42.31b) |
| Beneish M-Score: -3.54 (Cap -4..+1) = AAA |
What is the price of IMO shares?
As of March 07, 2026, the stock is trading at USD 118.20 with a total of 871,030 shares traded.
Over the past week, the price has changed by +1.31%, over one month by +5.46%, over three months by +31.15% and over the past year by +85.89%.
Over the past week, the price has changed by +1.31%, over one month by +5.46%, over three months by +31.15% and over the past year by +85.89%.
Is IMO a buy, sell or hold?
Imperial Oil has received a consensus analysts rating of 3.22.
Therefor, it is recommend to hold IMO.
- StrongBuy: 3
- Buy: 2
- Hold: 10
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the IMO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 77.4 | -34.5% |
| Analysts Target Price | 77.4 | -34.5% |
IMO Fundamental Data Overview March 05, 2026
Market Cap CAD = 81.24b (59.46b USD * 1.3662 USD.CAD)
P/E Trailing = 25.1709
P/E Forward = 25.641
P/S = 1.2674
P/B = 3.5293
P/EG = 0.85
Revenue TTM = 47.04b CAD
EBIT TTM = 4.25b CAD
EBITDA TTM = 6.83b CAD
Long Term Debt = 3.45b CAD (from longTermDebt, last quarter)
Short Term Debt = 19.0m CAD (from shortTermDebt, last quarter)
Debt = 4.98b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.84b CAD (from netDebt column, last quarter)
Enterprise Value = 85.08b CAD (81.24b + Debt 4.98b - CCE 1.14b)
Interest Coverage Ratio = 2126 (Ebit TTM 4.25b / Interest Expense TTM 2.00m)
EV/FCF = 18.09x (Enterprise Value 85.08b / FCF TTM 4.70b)
FCF Yield = 5.53% (FCF TTM 4.70b / Enterprise Value 85.08b)
FCF Margin = 10.00% (FCF TTM 4.70b / Revenue TTM 47.04b)
Net Margin = 6.94% (Net Income TTM 3.27b / Revenue TTM 47.04b)
Gross Margin = 21.23% ((Revenue TTM 47.04b - Cost of Revenue TTM 37.05b) / Revenue TTM)
Gross Margin QoQ = 41.72% (prev 11.21%)
Tobins Q-Ratio = 2.01 (Enterprise Value 85.08b / Total Assets 42.31b)
Interest Expense / Debt = -0.20% (Interest Expense -10.0m / Debt 4.98b)
Taxrate = 21.77% (136.2m / 625.5m)
NOPAT = 3.33b (EBIT 4.25b * (1 - 21.77%))
Current Ratio = 1.27 (Total Current Assets 8.42b / Total Current Liabilities 6.62b)
Debt / Equity = 0.22 (Debt 4.98b / totalStockholderEquity, last quarter 22.25b)
Debt / EBITDA = 0.56 (Net Debt 3.84b / EBITDA 6.83b)
Debt / FCF = 0.82 (Net Debt 3.84b / FCF TTM 4.70b)
Total Stockholder Equity = 22.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.66% (Net Income 3.27b / Total Assets 42.31b)
RoE = 14.73% (Net Income TTM 3.27b / Total Stockholder Equity 22.17b)
RoCE = 16.60% (EBIT 4.25b / Capital Employed (Equity 22.17b + L.T.Debt 3.45b))
RoIC = 12.18% (NOPAT 3.33b / Invested Capital 27.30b)
WACC = 8.43% (E(81.24b)/V(86.22b) * Re(8.96%) + D(4.98b)/V(86.22b) * Rd(-0.20%) * (1-Tc(0.22)))
Discount Rate = 8.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.93%
[DCF] Terminal Value 77.53% ; FCFF base≈4.47b ; Y1≈4.78b ; Y5≈5.78b
[DCF] Fair Price = 183.3 (EV 92.50b - Net Debt 3.84b = Equity 88.67b / Shares 483.6m; r=8.43% [WACC]; 5y FCF grow 7.74% → 2.90% )
EPS Correlation: -31.01 | EPS CAGR: 3.21% | SUE: 0.16 | # QB: 0
Revenue Correlation: -51.80 | Revenue CAGR: 1.16% | SUE: -0.46 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.55 | Chg7d=-0.011 | Chg30d=-0.123 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-12-31): EPS=6.87 | Chg7d=-0.028 | Chg30d=-0.043 | Revisions Net=-1 | Growth EPS=-19.5% | Growth Revenue=+7.3%
EPS next Year (2027-12-31): EPS=7.58 | Chg7d=-0.060 | Chg30d=-0.010 | Revisions Net=-2 | Growth EPS=+10.4% | Growth Revenue=+3.4%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.0% (Discount Rate 9.0% - Earnings Yield 4.0%)
[Growth] Growth Spread = -30.4% (Analyst -25.4% - Implied 5.0%)
P/E Trailing = 25.1709
P/E Forward = 25.641
P/S = 1.2674
P/B = 3.5293
P/EG = 0.85
Revenue TTM = 47.04b CAD
EBIT TTM = 4.25b CAD
EBITDA TTM = 6.83b CAD
Long Term Debt = 3.45b CAD (from longTermDebt, last quarter)
Short Term Debt = 19.0m CAD (from shortTermDebt, last quarter)
Debt = 4.98b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.84b CAD (from netDebt column, last quarter)
Enterprise Value = 85.08b CAD (81.24b + Debt 4.98b - CCE 1.14b)
Interest Coverage Ratio = 2126 (Ebit TTM 4.25b / Interest Expense TTM 2.00m)
EV/FCF = 18.09x (Enterprise Value 85.08b / FCF TTM 4.70b)
FCF Yield = 5.53% (FCF TTM 4.70b / Enterprise Value 85.08b)
FCF Margin = 10.00% (FCF TTM 4.70b / Revenue TTM 47.04b)
Net Margin = 6.94% (Net Income TTM 3.27b / Revenue TTM 47.04b)
Gross Margin = 21.23% ((Revenue TTM 47.04b - Cost of Revenue TTM 37.05b) / Revenue TTM)
Gross Margin QoQ = 41.72% (prev 11.21%)
Tobins Q-Ratio = 2.01 (Enterprise Value 85.08b / Total Assets 42.31b)
Interest Expense / Debt = -0.20% (Interest Expense -10.0m / Debt 4.98b)
Taxrate = 21.77% (136.2m / 625.5m)
NOPAT = 3.33b (EBIT 4.25b * (1 - 21.77%))
Current Ratio = 1.27 (Total Current Assets 8.42b / Total Current Liabilities 6.62b)
Debt / Equity = 0.22 (Debt 4.98b / totalStockholderEquity, last quarter 22.25b)
Debt / EBITDA = 0.56 (Net Debt 3.84b / EBITDA 6.83b)
Debt / FCF = 0.82 (Net Debt 3.84b / FCF TTM 4.70b)
Total Stockholder Equity = 22.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.66% (Net Income 3.27b / Total Assets 42.31b)
RoE = 14.73% (Net Income TTM 3.27b / Total Stockholder Equity 22.17b)
RoCE = 16.60% (EBIT 4.25b / Capital Employed (Equity 22.17b + L.T.Debt 3.45b))
RoIC = 12.18% (NOPAT 3.33b / Invested Capital 27.30b)
WACC = 8.43% (E(81.24b)/V(86.22b) * Re(8.96%) + D(4.98b)/V(86.22b) * Rd(-0.20%) * (1-Tc(0.22)))
Discount Rate = 8.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.93%
[DCF] Terminal Value 77.53% ; FCFF base≈4.47b ; Y1≈4.78b ; Y5≈5.78b
[DCF] Fair Price = 183.3 (EV 92.50b - Net Debt 3.84b = Equity 88.67b / Shares 483.6m; r=8.43% [WACC]; 5y FCF grow 7.74% → 2.90% )
EPS Correlation: -31.01 | EPS CAGR: 3.21% | SUE: 0.16 | # QB: 0
Revenue Correlation: -51.80 | Revenue CAGR: 1.16% | SUE: -0.46 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.55 | Chg7d=-0.011 | Chg30d=-0.123 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-12-31): EPS=6.87 | Chg7d=-0.028 | Chg30d=-0.043 | Revisions Net=-1 | Growth EPS=-19.5% | Growth Revenue=+7.3%
EPS next Year (2027-12-31): EPS=7.58 | Chg7d=-0.060 | Chg30d=-0.010 | Revisions Net=-2 | Growth EPS=+10.4% | Growth Revenue=+3.4%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.0% (Discount Rate 9.0% - Earnings Yield 4.0%)
[Growth] Growth Spread = -30.4% (Analyst -25.4% - Implied 5.0%)